[go: up one dir, main page]

HRP20170653T1 - Postupak za pripremanje 1-([1,3]dioksolan-4-ilmetil)-1h-pirazol-3-ilamina - Google Patents

Postupak za pripremanje 1-([1,3]dioksolan-4-ilmetil)-1h-pirazol-3-ilamina Download PDF

Info

Publication number
HRP20170653T1
HRP20170653T1 HRP20170653TT HRP20170653T HRP20170653T1 HR P20170653 T1 HRP20170653 T1 HR P20170653T1 HR P20170653T T HRP20170653T T HR P20170653TT HR P20170653 T HRP20170653 T HR P20170653T HR P20170653 T1 HRP20170653 T1 HR P20170653T1
Authority
HR
Croatia
Prior art keywords
formula
image
compound
phenyl
lithium
Prior art date
Application number
HRP20170653TT
Other languages
English (en)
Inventor
Junli Chen
Yi Ren
Jin She
Original Assignee
Hua Medicine, Maples Corporate Services Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hua Medicine, Maples Corporate Services Limited filed Critical Hua Medicine, Maples Corporate Services Limited
Publication of HRP20170653T1 publication Critical patent/HRP20170653T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • C07D231/40Acylated on said nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Claims (15)

1. Postupak za pripremanje spoja s formulom [image] pri čemu su R1 i R2 neovisno odabrani od vodika, C1-6alkila, C3-7cikloalkila, C3-6alkenila, ili fenila; pri čemu C1-6alkil, cikloalkil, C3-6alkenil ili fenil mogu proizvoljno biti supstituirani s halogenom, hidroksilom, C1-6alkoksikarbonilom, ili fenilom; ili R1 i R2, zajedno s ugljikom na koji su oni spojeni, tvore C3-7cikloalkil; naznačen time da sadrži slijedeće korake a) zaštitu 3-aminopirazola sa sredstvom za karboksilaciju u otapalu kod temperature reakcije između 20 i 100 °C da se dobije spoj s formulom (II); [image] pri čemu R3 je C1-6alkil, cikloalkil ili fenil; b) 1-supstituciju zaštićenog 3-aminopirazola s formulom (II) da se dobije spoj s formulom (III); [image] c) hidrolizu zaštićenog 3-aminopirazola s formulom (III) pod bazičnim uvjetima da se dobije spoj s formulom (I): [image]
2. Postupak prema zahtjevu 1, naznačen time da je za pripremanje spoja s formulom (Ia) [image]
3. Postupak prema zahtjevu 1 ili 2, naznačen time da spoj s formulom (I) ili (Ia) je 1-((R)2,2-dimetil-[1,3]dioksolan-4-ilmetil)-1H-pirazol-3-ilamin. [image]
4. Postupak prema zahtjevu 1, naznačen time da se korak a) provodi u otapalu koje je odabrano od tetrahidrofurana, octene kiseline, vode, izo-propil acetata ili etil acetata.
5. Postupak prema zahtjevima 1 ili 4, naznačen time da sredstvo za karboksilaciju je octeni anhidrid, acetil klorid, benzojev anhidrid, benzoil klorid ili pivaloil klorid.
6. Postupak prema bilo kojem od zahtjeva 1 do 5, naznačen time da se korak b) provodi sa sredstvom za alkilaciju u organskom otapalu s bazom i dodatkom litijeve soli kod temperature od 70 do 150 °C.
7. Postupak prema zahtjevu 6, naznačen time da je otapalo koje se koristi u koraku b) dimetilformamid, dimetilacetamid, N-metilpirolidinon ili dimetilsulfoksid.
8. Postupak prema zahtjevu 6 ili 7, naznačen time da baza u koraku b) je natrijeva, litijeva ili kalijeva sol alkoksida.
9. Postupak prema bilo kojem od zahtjeva 6 do 8, naznačen time da je litijeva sol koja se koristi u koraku b) litijev klorid, litijev bromid ili litijev jodid.
10. Postupak prema bilo kojem od zahtjeva 6 do 9, naznačen time da je sredstvo za alkilaciju u koraku b) [image] pri čemu su R1 i R2 definirani kao u zahtjevu 1 ili 3; R4 je klor, brom, jod ili -O-SO2-R5, pri čemu R5 je C1-6alkil, fenil ili fenil supstituiran s jednim do tri supstituenta koji su neovisno odabrani od C1-6alkila, halogena ili nitro.
11. Postupak prema bilo kojem od zahtjeva 1 do 10, naznačen time da sredstvo za alkilaciju u koraku b) je [image] pri čemu su R1, R2 i R4 definirani kao u zahtjevu 10.
12. Postupak prema bilo kojem od zahtjeva 1 do 10, naznačen time da se korak c) provodi u otapalu s bazom kod temperature od 40 do 100 °C.
13. Postupak prema zahtjevu 12, naznačen time da je otapalo korišteno u koraku c) metanol, etanol ili voda, ili njihova smjesa.
14. Postupak prema zahtjevima 12 ili 13, naznačen time da je baza korištena u koraku c) natrijev hidroksid, litijev hidroksid ili kalijev hidroksid.
15. Spoj s formulom (III); [image] naznačen time da R1 je metil, R2 je metil i R3 je metil.
HRP20170653TT 2012-12-25 2013-12-20 Postupak za pripremanje 1-([1,3]dioksolan-4-ilmetil)-1h-pirazol-3-ilamina HRP20170653T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2012087380 2012-12-25
PCT/EP2013/077563 WO2014102164A1 (en) 2012-12-25 2013-12-20 Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine
EP13811542.3A EP2938609B1 (en) 2012-12-25 2013-12-20 Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine

Publications (1)

Publication Number Publication Date
HRP20170653T1 true HRP20170653T1 (hr) 2017-06-30

Family

ID=49876646

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20170653TT HRP20170653T1 (hr) 2012-12-25 2013-12-20 Postupak za pripremanje 1-([1,3]dioksolan-4-ilmetil)-1h-pirazol-3-ilamina

Country Status (23)

Country Link
US (1) US9388168B2 (hr)
EP (1) EP2938609B1 (hr)
JP (1) JP6297590B2 (hr)
KR (1) KR102122569B1 (hr)
CN (1) CN105051031B (hr)
AU (1) AU2013369473B2 (hr)
BR (1) BR112015015229B1 (hr)
CA (1) CA2896155C (hr)
CY (1) CY1119040T1 (hr)
DK (1) DK2938609T3 (hr)
ES (1) ES2629313T3 (hr)
HR (1) HRP20170653T1 (hr)
HU (1) HUE032621T2 (hr)
IL (1) IL239558A (hr)
LT (1) LT2938609T (hr)
NZ (1) NZ709362A (hr)
PL (1) PL2938609T3 (hr)
PT (1) PT2938609T (hr)
RU (1) RU2621725C2 (hr)
SG (1) SG11201504951TA (hr)
SI (1) SI2938609T1 (hr)
WO (1) WO2014102164A1 (hr)
ZA (1) ZA201504601B (hr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11266630B2 (en) * 2016-12-15 2022-03-08 Hua Medicine (Shanghai) Ltd. Oral preparation of glucokinase activator and preparation method therefor
CN113493442B (zh) * 2020-04-03 2024-11-08 天津药物研究院有限公司 作为葡萄糖激酶活化剂的吡咯烷酮衍生物及其制备方法和用途
WO2021212360A1 (en) * 2020-04-22 2021-10-28 Hua Medicine (Shanghai) Ltd. Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor
US11813274B2 (en) 2020-04-22 2023-11-14 Hua Medicine (Shanghai) Ltd. Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor
CN111732543A (zh) * 2020-08-14 2020-10-02 浙江鼎龙科技有限公司 一种4,5-二氨基-1-(2-羟乙基)吡唑硫酸盐的制备方法
CN113750100B (zh) * 2021-08-31 2022-12-30 海南中济医药科技有限公司 一种含有多扎格列艾汀与西格列汀的药物组合物及其制备方法
AR127064A1 (es) * 2021-09-15 2023-12-13 Hua Medicine Shanghai Ltd Prodroga de derivados de pirrolidona como activador de glucoquinasa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160841A (en) * 1977-01-31 1979-07-10 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
FR2748274B1 (fr) * 1996-05-03 1998-06-12 Oreal Nouveaux diamino pyrazoles, leur synthese, compositions de teinture des fibres keratiniques les contenant, procede de teinture des fibres keratiniques
JP5287730B2 (ja) * 2008-01-18 2013-09-11 アステラス製薬株式会社 フェニルアセトアミド誘導体
US7741327B2 (en) * 2008-04-16 2010-06-22 Hoffmann-La Roche Inc. Pyrrolidinone glucokinase activators
US8178689B2 (en) * 2010-06-17 2012-05-15 Hoffman-La Roche Inc. Tricyclic compounds

Also Published As

Publication number Publication date
EP2938609B1 (en) 2017-04-12
AU2013369473A1 (en) 2015-07-16
PL2938609T3 (pl) 2017-08-31
RU2015126911A (ru) 2017-01-31
KR20150100809A (ko) 2015-09-02
HK1213262A1 (zh) 2016-06-30
CA2896155A1 (en) 2014-07-03
DK2938609T3 (en) 2017-05-15
SG11201504951TA (en) 2015-07-30
HUE032621T2 (en) 2017-10-30
AU2013369473B2 (en) 2017-03-09
SI2938609T1 (sl) 2017-07-31
JP6297590B2 (ja) 2018-03-20
IL239558A0 (en) 2015-08-31
BR112015015229A2 (pt) 2017-07-11
ES2629313T3 (es) 2017-08-08
CN105051031A (zh) 2015-11-11
US9388168B2 (en) 2016-07-12
US20150315176A1 (en) 2015-11-05
BR112015015229B1 (pt) 2020-07-07
LT2938609T (lt) 2017-06-26
JP2016503812A (ja) 2016-02-08
CN105051031B (zh) 2017-10-10
NZ709362A (en) 2019-07-26
ZA201504601B (en) 2016-10-26
PT2938609T (pt) 2017-07-04
CA2896155C (en) 2020-05-05
IL239558A (en) 2017-12-31
KR102122569B1 (ko) 2020-06-15
RU2621725C2 (ru) 2017-06-07
WO2014102164A1 (en) 2014-07-03
BR112015015229A8 (pt) 2019-10-15
CY1119040T1 (el) 2018-01-10
EP2938609A1 (en) 2015-11-04

Similar Documents

Publication Publication Date Title
HRP20170653T1 (hr) Postupak za pripremanje 1-([1,3]dioksolan-4-ilmetil)-1h-pirazol-3-ilamina
JP2015509939A5 (hr)
AR082891A1 (es) Di-azetidinil diamidas como inhibidores de monoacilglicerol lipasas
AR073892A1 (es) Proceso de preparacion de inhibidores de sglt
JP2015500335A5 (hr)
JP2017522357A5 (hr)
Zhou et al. Synthesis of indoles via palladium-catalyzed C–H activation of N-aryl amides followed by coupling with alkynes
ES2512591T3 (es) Método de producción de 2'-desoxi-5-azacitidina (decitabina)
HRP20150945T1 (hr) Postupci za proizvodnju derivata benzil-benzena supstituiranog glukopiranozilom
BR112014004210B1 (pt) processo para a preparação de derivados de diamida do ácido antranílico substituídos com tetrazole por reação de benzoxazinonas com aminas
Stopka et al. Metal free carboamination of internal alkynes–an easy access to polysubstituted quinolines
BR112014000471B1 (pt) processo para preparo de derivados de diamida de ácido antranílico substituídos com tetrazol por meio da reação de ácidos pirazóis com ésteres antranílicos
EP2269975B1 (en) Method for producing aminothiazole derivative and production intermediate
JP2016503812A5 (hr)
RU2014128826A (ru) Дисоли малоновой кислоты и способ получения малонилдигалогенидов
RU2012122367A (ru) Способ получения простагландинов и промежуточные соединения для их получения
HRP20151439T1 (hr) Halogenirani derivati benzamida
TWI434835B (zh) 苯達莫司汀烷酯、苯達莫司汀及其衍生物之生產方法
RU2004139100A (ru) Способ получения производных пенама из производных цефама
AR092070A1 (es) Proceso para la preparacion de inhibidores de quinasa c-fms
CN108017593B (zh) 一种简便高效的1-氧-4,5-二氮杂环庚烷合成方法
ES2597853T3 (es) Procedimiento para la preparación de ésteres alquílicos de ácido dihaloacetoacético
JP2010516779A5 (hr)
HRP20170394T1 (hr) Postupak za sintezu 3,4-dimetoksibiciklo[4.2.0]okta-1,3,5-trien-7-karbonitrila i uporaba za sintezu ivabadina i njegovih adicijskih soli s farmacetuski prihvatljivom kiselinom
CN109535140A (zh) 一种基于肟酯与吲哚构建双吲哚取代二氢吡咯酮类衍生物的方法